BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Xiang Y, Xin VW, Wang XW, Peng XC, Liu XQ, Wang D, Li N, Cheng JT, Lyv YN, Cui SZ, Ma Z, Zhang Q, Xin HW. Dendritic cell biology and its role in tumor immunotherapy. J Hematol Oncol 2020;13:107. [PMID: 32746880 DOI: 10.1186/s13045-020-00939-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 Gong P, Wang Y, Zhang P, Yang Z, Deng W, Sun Z, Yang M, Li X, Ma G, Deng G, Dong S, Cai L, Jiang W. Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy. Cancers (Basel) 2020;13:E77. [PMID: 33396603 DOI: 10.3390/cancers13010077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Vukadin S, Khaznadar F, Kizivat T, Vcev A, Smolic M. Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update. Biomedicines 2021;9:835. [PMID: 34356899 DOI: 10.3390/biomedicines9070835] [Reference Citation Analysis]
3 Kai K, Tanaka T, Ide T, Kawaguchi A, Noshiro H, Aishima S. Immunohistochemical analysis of the aggregation of CD1a-positive dendritic cells in resected specimens and its association with surgical outcomes for patients with gallbladder cancer. Transl Oncol 2021;14:100923. [PMID: 33129106 DOI: 10.1016/j.tranon.2020.100923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Guan Y, Wang N, Deng Z, Chen X, Liu Y. Exploiting autophagy-regulative nanomaterials for activation of dendritic cells enables reinforced cancer immunotherapy. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121434] [Reference Citation Analysis]
5 Bednarczyk M, Medina-Montano C, Fittler FJ, Stege H, Roskamp M, Kuske M, Langer C, Vahldieck M, Montermann E, Tubbe I, Röhrig N, Dzionek A, Grabbe S, Bros M. Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 Cells. Int J Mol Sci 2021;22:2869. [PMID: 33799879 DOI: 10.3390/ijms22062869] [Reference Citation Analysis]
6 Chen Q, Zhang L, Li L, Tan M, Liu W, Liu S, Xie Z, Zhang W, Wang Z, Cao Y, Shang T, Ran H. Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer. J Nanobiotechnology 2021;19:449. [PMID: 34952587 DOI: 10.1186/s12951-021-01202-x] [Reference Citation Analysis]
7 Payandeh Z, Pirpour Tazehkand A, Azargoonjahromi A, Almasi F, Alagheband Bahrami A. The Role of Cell Organelles in Rheumatoid Arthritis with Focus on Exosomes. Biol Proced Online 2021;23:20. [PMID: 34736402 DOI: 10.1186/s12575-021-00158-4] [Reference Citation Analysis]
8 Yu J, Wang Q, Zhang X, Guo Z, Cui X. Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications. Front Oncol 2021;11:685377. [PMID: 34123855 DOI: 10.3389/fonc.2021.685377] [Reference Citation Analysis]
9 Vogelzang NJ, Beer TM, Gerritsen W, Oudard S, Wiechno P, Kukielka-Budny B, Samal V, Hajek J, Feyerabend S, Khoo V, Stenzl A, Csöszi T, Filipovic Z, Goncalves F, Prokhorov A, Cheung E, Hussain A, Sousa N, Bahl A, Hussain S, Fricke H, Kadlecova P, Scheiner T, Korolkiewicz RP, Bartunkova J, Spisek R; VIABLE Investigators. Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial. JAMA Oncol 2022. [PMID: 35142815 DOI: 10.1001/jamaoncol.2021.7298] [Reference Citation Analysis]
10 Naimi A, Yashmi I, Jebeleh R, Imani Mofrad M, Azimian Abhar S, Jannesar Y, Heidary M, Pakzad R. Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis. J Clin Lab Anal 2022;:e24387. [PMID: 35385130 DOI: 10.1002/jcla.24387] [Reference Citation Analysis]
11 Li SJ, Chen JX, Sun ZJ. Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges. Cancer Commun (Lond) 2021. [PMID: 34137513 DOI: 10.1002/cac2.12183] [Reference Citation Analysis]
12 Yu W, Lei Q, Yang L, Qin G, Liu S, Wang D, Ping Y, Zhang Y. Contradictory roles of lipid metabolism in immune response within the tumor microenvironment. J Hematol Oncol 2021;14:187. [PMID: 34742349 DOI: 10.1186/s13045-021-01200-4] [Reference Citation Analysis]
13 Ye J, Gao Y, Ji M, Yang Y, Wang Z, Wang B, Jin J, Li L, Wang H, Xu X, Liao H, Lian C, Xu Y, Li R, Sun T, Gao L, Li Y, Chen X, Liu Y. Oral SMEDDS promotes lymphatic transport and mesenteric lymph nodes target of chlorogenic acid for effective T-cell antitumor immunity. J Immunother Cancer 2021;9:e002753. [PMID: 34272308 DOI: 10.1136/jitc-2021-002753] [Reference Citation Analysis]
14 Li H, Yu Z, Wang H, Wang N, Sun X, Yang S, Hua X, Liu Z. Role of ANO1 in tumors and tumor immunity. J Cancer Res Clin Oncol 2022. [PMID: 35471604 DOI: 10.1007/s00432-022-04004-2] [Reference Citation Analysis]
15 Heng X, Feng R, Zhu L, Yu L, Chen G, Chen H. Dendritic cells maturation facilitated by group-adjustable lipopolysaccharide analogues synthesized via RAFT polymerization. Chinese Chemical Letters 2021. [DOI: 10.1016/j.cclet.2021.12.032] [Reference Citation Analysis]
16 Gaglio SC, Donini M, Denbaes PE, Dusi S, Perduca M. Oxyresveratrol Inhibits R848-Induced Pro-Inflammatory Mediators Release by Human Dendritic Cells Even When Embedded in PLGA Nanoparticles. Molecules 2021;26:2106. [PMID: 33916909 DOI: 10.3390/molecules26082106] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Shadbad MA, Hajiasgharzadeh K, Derakhshani A, Silvestris N, Baghbanzadeh A, Racanelli V, Baradaran B. From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past. Front Immunol 2021;12:623639. [PMID: 33692796 DOI: 10.3389/fimmu.2021.623639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
18 Oshi M, Newman S, Tokumaru Y, Yan L, Matsuyama R, Kalinski P, Endo I, Takabe K. Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC). Cancers (Basel) 2020;12:E3342. [PMID: 33198125 DOI: 10.3390/cancers12113342] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
19 Barati M, Akhondi M, Mousavi NS, Haghparast N, Ghodsi A, Baharvand H, Ebrahimi M, Hassani SN. Pluripotent Stem Cells: Cancer Study, Therapy, and Vaccination. Stem Cell Rev Rep 2021. [PMID: 34115316 DOI: 10.1007/s12015-021-10199-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Datsi A, Sorg RV. Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End. Front Immunol 2021;12:770390. [PMID: 34795675 DOI: 10.3389/fimmu.2021.770390] [Reference Citation Analysis]
21 Basheer AS, Abas F, Othman I, Naidu R. Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications. Cancers (Basel) 2021;13:4226. [PMID: 34439380 DOI: 10.3390/cancers13164226] [Reference Citation Analysis]
22 Kapor S, Santibanez JF. Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies. J Clin Med 2021;10:2788. [PMID: 34202907 DOI: 10.3390/jcm10132788] [Reference Citation Analysis]
23 Xie S, Hou X, Yang W, Shi W, Yang X, Duan S, Mo F, Liu A, Wang W, Lu X. Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects. Int J Nanomedicine 2021;16:6017-34. [PMID: 34511903 DOI: 10.2147/IJN.S317220] [Reference Citation Analysis]
24 Zhou S, Fan C, Zeng Z, Young KH, Li Y. Clinical and Immunological Effects of p53-Targeting Vaccines. Front Cell Dev Biol 2021;9:762796. [PMID: 34805170 DOI: 10.3389/fcell.2021.762796] [Reference Citation Analysis]
25 Ruan S, Erwin N, He M. Light-induced high-efficient cellular production of immune functional extracellular vesicles. J Extracell Vesicles 2022;11:e12194. [PMID: 35230743 DOI: 10.1002/jev2.12194] [Reference Citation Analysis]
26 Wu J, Sun J, Meng X. Pyroptosis by caspase-11 inflammasome-Gasdermin D pathway in autoimmune diseases. Pharmacol Res 2021;165:105408. [PMID: 33412278 DOI: 10.1016/j.phrs.2020.105408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zhu S, Zhang T, Zheng L, Liu H, Song W, Liu D, Li Z, Pan CX. Combination strategies to maximize the benefits of cancer immunotherapy. J Hematol Oncol 2021;14:156. [PMID: 34579759 DOI: 10.1186/s13045-021-01164-5] [Reference Citation Analysis]
28 Yang Y, Wang K, Pan Y, Rao L, Luo G. Engineered Cell Membrane-Derived Nanoparticles in Immune Modulation. Adv Sci (Weinh) 2021;:e2102330. [PMID: 34693653 DOI: 10.1002/advs.202102330] [Reference Citation Analysis]
29 Li X, Liu Y, Zheng S, Zhang T, Wu J, Sun Y, Zhang J, Liu G. Role of exosomes in the immune microenvironment of ovarian cancer. Oncol Lett 2021;21:377. [PMID: 33777201 DOI: 10.3892/ol.2021.12638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Wang YH, Lin CC, Yao CY, Hsu CL, Tsai CH, Hou HA, Chou WC, Tien HF. Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome. Br J Haematol 2021. [PMID: 34536013 DOI: 10.1111/bjh.17837] [Reference Citation Analysis]
31 Wang T, Zhang J, Li N, Li M, Ma S, Tan S, Guo X, Wang Z, Wu Z, Gao L, Ma C, Liang X. Spatial distribution and functional analysis define the action pathway of Tim-3/Tim-3 ligands in tumor development. Mol Ther 2021:S1525-0016(21)00586-4. [PMID: 34808386 DOI: 10.1016/j.ymthe.2021.11.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Zhou S, Sun X, Jin Z, Yang H, Ye W. The role of autophagy in initiation, progression, TME modification, diagnosis, and treatment of esophageal cancers. Crit Rev Oncol Hematol 2022;:103702. [PMID: 35577254 DOI: 10.1016/j.critrevonc.2022.103702] [Reference Citation Analysis]
33 Mortezaee K, Majidpoor J. The impact of hypoxia on immune state in cancer. Life Sci 2021;286:120057. [PMID: 34662552 DOI: 10.1016/j.lfs.2021.120057] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Yu J, Sun H, Cao W, Song Y, Jiang Z. Research progress on dendritic cell vaccines in cancer immunotherapy. Exp Hematol Oncol 2022;11:3. [PMID: 35074008 DOI: 10.1186/s40164-022-00257-2] [Reference Citation Analysis]
35 DeLucia DC, Lee JK. Development of Cancer Immunotherapies. Cancer Treat Res 2022;183:1-48. [PMID: 35551655 DOI: 10.1007/978-3-030-96376-7_1] [Reference Citation Analysis]
36 Zhou B, Lawrence T, Liang Y. The Role of Plasmacytoid Dendritic Cells in Cancers. Front Immunol 2021;12:749190. [PMID: 34737750 DOI: 10.3389/fimmu.2021.749190] [Reference Citation Analysis]
37 Liu Y, Zhou X, Wang X. Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities. J Hematol Oncol 2021;14:125. [PMID: 34404434 DOI: 10.1186/s13045-021-01134-x] [Reference Citation Analysis]
38 Mojsilovic S, Mojsilovic SS, Bjelica S, Santibanez JF. Transforming growth factor-beta1 and myeloid-derived suppressor cells: A cancerous partnership. Dev Dyn 2021. [PMID: 33797140 DOI: 10.1002/dvdy.339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Suga Y, Nagatomo I, Kinehara Y, Koyama S, Okuzaki D, Osa A, Naito Y, Takamatsu H, Nishide M, Nojima S, Ito D, Tsuda T, Nakatani T, Nakanishi Y, Futami Y, Koba T, Satoh S, Hosono Y, Miyake K, Fukushima K, Shiroyama T, Iwahori K, Hirata H, Takeda Y, Kumanogoh A. IL-33 Induces Sema4A Expression in Dendritic Cells and Exerts Antitumor Immunity. J Immunol 2021;207:1456-67. [PMID: 34380650 DOI: 10.4049/jimmunol.2100076] [Reference Citation Analysis]
40 Zhou L, Shen M, Fan X, Liu Y, Yang L. Pathogenic and Potential Therapeutic Roles of Exosomes Derived From Immune Cells in Liver Diseases. Front Immunol 2022;13:810300. [DOI: 10.3389/fimmu.2022.810300] [Reference Citation Analysis]
41 Zhao X, Pan X, Wang Y, Zhang Y. Targeting neoantigens for cancer immunotherapy. Biomark Res 2021;9:61. [PMID: 34321091 DOI: 10.1186/s40364-021-00315-7] [Reference Citation Analysis]
42 Chen H, Zhang P, Shi Y, Liu C, Zhou Q, Zeng Y, Cheng H, Dai Q, Gao X, Wang X, Liu G. Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy. J Nanobiotechnology 2022;20:61. [PMID: 35109867 DOI: 10.1186/s12951-022-01266-3] [Reference Citation Analysis]
43 Guo R, Lü M, Cao F, Wu G, Gao F, Pang H, Li Y, Zhang Y, Xing H, Liang C, Lyu T, Du C, Li Y, Guo R, Xie X, Li W, Liu D, Song Y, Jiang Z. Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment. Biomark Res 2021;9:15. [PMID: 33648605 DOI: 10.1186/s40364-021-00265-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
44 Xu X, Sui B, Liu X, Sun J. Superior low-immunogenicity of tilapia type I collagen based on unique secondary structure with single calcium binding motif over terrestrial mammals by inhibiting activation of DC intracellular Ca2+-mediated STIM1-Orai1/NF-кB pathway. Mater Sci Eng C Mater Biol Appl 2021;131:112503. [PMID: 34857289 DOI: 10.1016/j.msec.2021.112503] [Reference Citation Analysis]
45 Zhuang B, Chen T, Huang Y, Xiao Z, Jin Y. Chemo-photothermal immunotherapy for eradication of orthotopic tumors and inhibition of metastasis by intratumoral injection of polydopamine versatile hydrogels. Acta Pharmaceutica Sinica B 2022;12:1447-59. [DOI: 10.1016/j.apsb.2021.09.001] [Reference Citation Analysis]
46 Mirian M, Hariri A, Yadollahi M, Kohandel M. Circadian and Immunity Cycle Talk in Cancer Destination: From Biological Aspects to In Silico Analysis. Cancers 2022;14:1578. [DOI: 10.3390/cancers14061578] [Reference Citation Analysis]
47 Chen L, Musa AE. Boosting immune system against cancer by resveratrol. Phytother Res 2021. [PMID: 34101276 DOI: 10.1002/ptr.7189] [Reference Citation Analysis]
48 Sun C, Nagaoka K, Kobayashi Y, Nakagawa H, Kakimi K, Nakajima J. Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1. Cancers (Basel) 2021;13:5508. [PMID: 34771674 DOI: 10.3390/cancers13215508] [Reference Citation Analysis]
49 Zhang L, Xu L, Wang Y, Liu J, Tan G, Huang F, He N, Lu Z. A novel therapeutic vaccine based on graphene oxide nanocomposite for tumor immunotherapy. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.01.071] [Reference Citation Analysis]
50 Amendt T, Jumaa H. Adaptive tolerance: Protection through self-recognition. Bioessays 2022;:e2100236. [PMID: 34984705 DOI: 10.1002/bies.202100236] [Reference Citation Analysis]
51 Liu L, Zhou Y, Dong X, Li S, Cheng S, Li H, Li Y, Yuan J, Wang L, Dong J, Li X. HOTAIRM1 Maintained the Malignant Phenotype of tMSCs Transformed by GSCs via E2F7 by Binding to FUS. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/7734413] [Reference Citation Analysis]
52 Sun Z, Sun X, Chen Z, Du J, Wu Y. Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines. Int J Pept Res Ther 2022;28:19. [PMID: 34903958 DOI: 10.1007/s10989-021-10334-5] [Reference Citation Analysis]
53 Huang SL, Wang YM, Wang QY, Feng GG, Wu FQ, Yang LM, Zhang XH, Xin HW. Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy. Front Genet 2021;12:691391. [PMID: 34306031 DOI: 10.3389/fgene.2021.691391] [Reference Citation Analysis]
54 Chugh V, Vijaya Krishna K, Pandit A. Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation. ACS Nano 2021. [PMID: 34699181 DOI: 10.1021/acsnano.1c03800] [Reference Citation Analysis]
55 Abadi B, Yazdanpanah N, Nokhodchi A, Rezaei N. Smart biomaterials to enhance the efficiency of immunotherapy in glioblastoma: State of the art and future perspectives. Adv Drug Deliv Rev 2021;179:114035. [PMID: 34740765 DOI: 10.1016/j.addr.2021.114035] [Reference Citation Analysis]
56 Guo H, Hu R, Huang G, Pu W, Chu X, Xing C, Zhang C. Molybdenum and cadmium co-exposure induces endoplasmic reticulum stress-mediated apoptosis by Th1 polarization in Shaoxing duck (Anas platyrhyncha) spleens. Chemosphere 2022;298:134275. [DOI: 10.1016/j.chemosphere.2022.134275] [Reference Citation Analysis]
57 Wangmo D, Premsrirut PK, Yuan C, Morris WS, Zhao X, Subramanian S. ACKR4 in Tumor Cells Regulates Dendritic Cell Migration to Tumor-Draining Lymph Nodes and T-Cell Priming. Cancers (Basel) 2021;13:5021. [PMID: 34638505 DOI: 10.3390/cancers13195021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Li X, Yong T, Wei Z, Bie N, Zhang X, Zhan G, Li J, Qin J, Yu J, Zhang B, Gan L, Yang X. Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts. Nat Commun 2022;13:2794. [PMID: 35589680 DOI: 10.1038/s41467-022-30306-7] [Reference Citation Analysis]